# Oncora Medical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/oncora-medical

- Industry: Software
- Headquarters: Philadelphia, US
- Website: www.oncoramedical.com
- Total disclosed funding: $1.2M
- Latest round: Seed (Mar 10, 2016)
- Investors on record: 3

## About

Oncora Medical, LLC develops oncology-specific artificial intelligence solutions aimed at enhancing clinical workflows and improving data management for healthcare professionals involved in cancer treatment.Oncora Medical, LLC focuses on providing advanced artificial intelligence solutions for oncology. Founded in 2014 and headquartered in Philadelphia, US, the company was established to streamline oncology data management. Christopher Berlind is the founder, and David Lindsay is the current CEO. Oncora Medical has secured a total investment of USD 1.2 mn in Seed funding, with the most recent deal occurring on March 10, 2016, backed by investors including iSeed Ventures and BioAdvance.Oncora Medical specializes in oncology-specific artificial intelligence solutions designed to enhance clinical workflows and improve data management within cancer registries. The company offers solutions like Registry AI, which optimizes data collection and analysis, and Clinical AI, which incorporates an AI scribe to assist with oncology-specific documentation. These tools are aimed at cancer registry professionals and clinical care teams, focusing primarily on markets in the United States and Canada.Oncora Medical operates on a subscription-based model, establishing multi-year contracts with healthcare providers and institutions that grant access to both Registry AI and Clinical AI solutions. The pricing structure includes tiered subscription plans tailored to the needs of healthcare organizations, aiming to enhance operational efficiency and clinical outcomes.With the recent Seed funding of USD 1.2 mn raised in March 2016, Oncora Medical plans to utilize these resources to expand its product offerings and enhance its artificial intelligence solutions. The company is focused on launching new features for Registry AI and Clinical AI, targeting to enter additional markets in North America by 2025, thereby addressing the growing demand for efficient oncology data management.

## Funding rounds

- Seed, Mar 10, 2016, $1.2M — BioAdvance, iSeed Ventures
- Seed, Jan 23, 2015 — Dorm Room Fund

## Investors

- Dorm Room Fund (https://capitalatlas.ai/funds/dorm-room-fund) — Seed
- BioAdvance (https://capitalatlas.ai/funds/bioadvance) — Seed
- iSeed Ventures (https://capitalatlas.ai/funds/iseed-ventures) — Seed